Moderna’s Sales Miss Forecasts by 20%. Pfizer Is Taking the U.S. Vaccine Market.

3 years ago 387

Moderna shares plunged 12.3% successful premarket trading connected Thursday aft income of the company’s Covid-19 vaccine fell abbreviated of Wall Street analysts’ estimates by much than a cardinal dollars.

The institution reported full gross of $5 cardinal for the 3rd 4th of the year, 20% abbreviated of the FactSet expert statement estimation of $6.2 billion. Spikevax, Moderna‘s (ticker: MRNA) Covid-19 vaccine, is the company’s lone product.

The...

Read Entire Article

Moderna’s Sales Miss Forecasts by 20%. Pfizer Is Taking the U.S. Vaccine Market.

Related

How Can We Boost Our Online Influence with Expert Guest Post...

J.P. Morgan’s 2 Stock Picks With Over 80% Upside Potential

A 27-year-old truck driver just became Robinhood’s first big...

AT&T Stock Has Fallen to a Multi-Decade Low. Why It Could Be...

Trending

Popular

$1 Million in Fines Proposed Over Nitrogen Leak That Killed ...

Biden Officials Now Expect Vulnerable Americans to Need Boos...

First match in Tokyo called off due to COVID

USA's explosive $90m lawsuit hits Olympics

Vacuuming DNA from air can reveal which animals are present ...